Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Clinical trial NCT05914909 · COMPLETED
Trial details
- NCT number
- NCT05914909
- Sponsor
- AdAlta Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-17
- Primary completion
- 2024-02-09
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.